Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) shares saw strong trading volume on Thursday . 222,710 shares traded hands during mid-day trading, an increase of 169% from the previous session’s volume of 82,759 shares.The stock last traded at $54.57 and had previously closed at $53.96.
Novozymes A/S Trading Up 1.0%
The company has a market cap of $22.58 billion, a PE ratio of 38.91, a P/E/G ratio of 0.99 and a beta of 1.11. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 0.26. The business’s 50-day simple moving average is $61.50 and its 200-day simple moving average is $62.12.
Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) last posted its earnings results on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.44). Novozymes A/S had a net margin of 13.96% and a return on equity of 6.38%. The business had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.22 billion. As a group, analysts expect that Novozymes A/S will post 1.82 EPS for the current fiscal year.
Novozymes A/S Company Profile
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
Recommended Stories
- Five stocks we like better than Novozymes A/S
- The Forbes Mineral America Needs
- How China Accidentally Created Its Own Rare Earth Rival
- Legendary Investors Dumping Nvidia. AI Meltdown Next? SSL: Prepare now
- The largest IPO in history is coming
- Read this or regret it forever
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
